Fewer acute respiratory infection episodes among patients receiving treatment for gastroesophageal reflux disease

Herng Ching Lin, Sudha Xirasagar, Shiu Dong Chung, Chung Chien Huang, Ming Chieh Tsai, Chao Hung Chen

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Patients with gastroesophageal reflux disease (GERD) present with comorbid complications with implications for healthcare utilization. To date, little is known about the effects of GERD treatment with a proton-pump inhibitor (PPI) on patients' subsequent healthcare utilization for acute respiratory infections (ARIs). This population-based study compared ARI episodes captured through outpatient visits, one year before and one year after GERD patients received PPI treatment. We used retrospective data from the Longitudinal Health Insurance Database 2005 in Taiwan, comparing 21,486 patients diagnosed with GERD from 2010 to2012 with 21,486 age-sex matched comparison patients without GERD. Annual ARI episodes represented by ambulatory care visits for ARI (visits during a 7-day period bundled into one episode), were compared between the patient groups during the 1-year period before and after the index date (date of GERD diagnosis for study patients, first ambulatory visit in the same year for their matched comparison counterpart). Multiple regression analysis using a difference-in-difference approach was performed to estimate the adjusted association between GERD treatment and the subsequent annual ARI rate. We found that the mean annual ARI episode rate among GERD patients reduced by 11.4%, from 4.39 before PPI treatment, to 3.89 following treatment (mean change = -0.5 visit, 95% confidence interval (CI) = (-0.64, -0.36)). In Poisson regression analysis, GERD treatment showed an independent association with the annual ARI rate, showing a negative estimate (with p<0.001).The study suggests that GERD treatment with PPIs may help reduce healthcare visits for ARIs, highlighting the importance of treatment-seeking by GERD patients and compliance with treatment.

Original languageEnglish
Article numbere0172436
JournalPLoS One
Volume12
Issue number2
DOIs
Publication statusPublished - Feb 1 2017

Fingerprint

gastroesophageal reflux
Gastroesophageal Reflux
Respiratory Tract Infections
infection
Proton Pump Inhibitors
Therapeutics
health services
Respiratory Rate
Delivery of Health Care
Regression analysis
regression analysis
Regression Analysis
Health insurance
health insurance
disease diagnosis
Health Insurance
Patient Compliance
Ambulatory Care
Taiwan
compliance

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Fewer acute respiratory infection episodes among patients receiving treatment for gastroesophageal reflux disease. / Lin, Herng Ching; Xirasagar, Sudha; Chung, Shiu Dong; Huang, Chung Chien; Tsai, Ming Chieh; Chen, Chao Hung.

In: PLoS One, Vol. 12, No. 2, e0172436, 01.02.2017.

Research output: Contribution to journalArticle

Lin, Herng Ching ; Xirasagar, Sudha ; Chung, Shiu Dong ; Huang, Chung Chien ; Tsai, Ming Chieh ; Chen, Chao Hung. / Fewer acute respiratory infection episodes among patients receiving treatment for gastroesophageal reflux disease. In: PLoS One. 2017 ; Vol. 12, No. 2.
@article{569370ca4dd1454994c6539550771b58,
title = "Fewer acute respiratory infection episodes among patients receiving treatment for gastroesophageal reflux disease",
abstract = "Patients with gastroesophageal reflux disease (GERD) present with comorbid complications with implications for healthcare utilization. To date, little is known about the effects of GERD treatment with a proton-pump inhibitor (PPI) on patients' subsequent healthcare utilization for acute respiratory infections (ARIs). This population-based study compared ARI episodes captured through outpatient visits, one year before and one year after GERD patients received PPI treatment. We used retrospective data from the Longitudinal Health Insurance Database 2005 in Taiwan, comparing 21,486 patients diagnosed with GERD from 2010 to2012 with 21,486 age-sex matched comparison patients without GERD. Annual ARI episodes represented by ambulatory care visits for ARI (visits during a 7-day period bundled into one episode), were compared between the patient groups during the 1-year period before and after the index date (date of GERD diagnosis for study patients, first ambulatory visit in the same year for their matched comparison counterpart). Multiple regression analysis using a difference-in-difference approach was performed to estimate the adjusted association between GERD treatment and the subsequent annual ARI rate. We found that the mean annual ARI episode rate among GERD patients reduced by 11.4{\%}, from 4.39 before PPI treatment, to 3.89 following treatment (mean change = -0.5 visit, 95{\%} confidence interval (CI) = (-0.64, -0.36)). In Poisson regression analysis, GERD treatment showed an independent association with the annual ARI rate, showing a negative estimate (with p<0.001).The study suggests that GERD treatment with PPIs may help reduce healthcare visits for ARIs, highlighting the importance of treatment-seeking by GERD patients and compliance with treatment.",
author = "Lin, {Herng Ching} and Sudha Xirasagar and Chung, {Shiu Dong} and Huang, {Chung Chien} and Tsai, {Ming Chieh} and Chen, {Chao Hung}",
year = "2017",
month = "2",
day = "1",
doi = "10.1371/journal.pone.0172436",
language = "English",
volume = "12",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "2",

}

TY - JOUR

T1 - Fewer acute respiratory infection episodes among patients receiving treatment for gastroesophageal reflux disease

AU - Lin, Herng Ching

AU - Xirasagar, Sudha

AU - Chung, Shiu Dong

AU - Huang, Chung Chien

AU - Tsai, Ming Chieh

AU - Chen, Chao Hung

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Patients with gastroesophageal reflux disease (GERD) present with comorbid complications with implications for healthcare utilization. To date, little is known about the effects of GERD treatment with a proton-pump inhibitor (PPI) on patients' subsequent healthcare utilization for acute respiratory infections (ARIs). This population-based study compared ARI episodes captured through outpatient visits, one year before and one year after GERD patients received PPI treatment. We used retrospective data from the Longitudinal Health Insurance Database 2005 in Taiwan, comparing 21,486 patients diagnosed with GERD from 2010 to2012 with 21,486 age-sex matched comparison patients without GERD. Annual ARI episodes represented by ambulatory care visits for ARI (visits during a 7-day period bundled into one episode), were compared between the patient groups during the 1-year period before and after the index date (date of GERD diagnosis for study patients, first ambulatory visit in the same year for their matched comparison counterpart). Multiple regression analysis using a difference-in-difference approach was performed to estimate the adjusted association between GERD treatment and the subsequent annual ARI rate. We found that the mean annual ARI episode rate among GERD patients reduced by 11.4%, from 4.39 before PPI treatment, to 3.89 following treatment (mean change = -0.5 visit, 95% confidence interval (CI) = (-0.64, -0.36)). In Poisson regression analysis, GERD treatment showed an independent association with the annual ARI rate, showing a negative estimate (with p<0.001).The study suggests that GERD treatment with PPIs may help reduce healthcare visits for ARIs, highlighting the importance of treatment-seeking by GERD patients and compliance with treatment.

AB - Patients with gastroesophageal reflux disease (GERD) present with comorbid complications with implications for healthcare utilization. To date, little is known about the effects of GERD treatment with a proton-pump inhibitor (PPI) on patients' subsequent healthcare utilization for acute respiratory infections (ARIs). This population-based study compared ARI episodes captured through outpatient visits, one year before and one year after GERD patients received PPI treatment. We used retrospective data from the Longitudinal Health Insurance Database 2005 in Taiwan, comparing 21,486 patients diagnosed with GERD from 2010 to2012 with 21,486 age-sex matched comparison patients without GERD. Annual ARI episodes represented by ambulatory care visits for ARI (visits during a 7-day period bundled into one episode), were compared between the patient groups during the 1-year period before and after the index date (date of GERD diagnosis for study patients, first ambulatory visit in the same year for their matched comparison counterpart). Multiple regression analysis using a difference-in-difference approach was performed to estimate the adjusted association between GERD treatment and the subsequent annual ARI rate. We found that the mean annual ARI episode rate among GERD patients reduced by 11.4%, from 4.39 before PPI treatment, to 3.89 following treatment (mean change = -0.5 visit, 95% confidence interval (CI) = (-0.64, -0.36)). In Poisson regression analysis, GERD treatment showed an independent association with the annual ARI rate, showing a negative estimate (with p<0.001).The study suggests that GERD treatment with PPIs may help reduce healthcare visits for ARIs, highlighting the importance of treatment-seeking by GERD patients and compliance with treatment.

UR - http://www.scopus.com/inward/record.url?scp=85013630125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013630125&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0172436

DO - 10.1371/journal.pone.0172436

M3 - Article

C2 - 28222168

AN - SCOPUS:85013630125

VL - 12

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 2

M1 - e0172436

ER -